skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Prediction of radiation dosimetry in patients with thyroid cancer using a Gamma camera

Conference · · J. Nucl. Med.; (United States)
OSTI ID:5935532

Radioiodine in the thyroid or cervical metastases, and therefore radiation dosimetry, can be determined using a probe and phantom. This approach is not ideal for quantitating radioiodine and dosimetry for sites elsewhere in the body. The authors have studied the use of gamma camera methods in association with I-123 to predict the distribution of I-131 and its dosimetry in 3 patients with metastatic thyroid cancer. Images and urine were obtained after administration of tracer I-123 and treatment I-131 to each patient. The geometric mean of counts from anterior and posterior total body camera scans were used to determine body clearance. Organ or metastasis radioactvity and dosimetry were quantitated using planar images and SPECT. Uptake, clearance and dosimetry of structures, such as thyroid and nodular metastases in the lung, could be determined. In summary, a gamma camera method for improved quantitation of radioiodine distribution in the body has been explored. It provides quantitative pharmacokinetics which give better estimates of distribution of radiation dose. This information offers a less empirical approach to the treatment of thyroid cancer with I-131, and other cancers with radiolabeled antibodies.

Research Organization:
Univ. of California Davis Medical Center, Sacramento, CA
OSTI ID:
5935532
Report Number(s):
CONF-850611-; TRN: 87-039620
Journal Information:
J. Nucl. Med.; (United States), Vol. 26:5; Conference: 32. annual meeting of the Society of Nuclear Medicine, Houston, TX, USA, 2 Jun 1985
Country of Publication:
United States
Language:
English